Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators.
about
The role of water in activation mechanism of human N-formyl peptide receptor 1 (FPR1) based on molecular dynamics simulationsHorizons in therapy for corneal angiogenesis.Roles of resolvins in the resolution of acute inflammationThe specialized proresolving mediator 17-HDHA enhances the antibody-mediated immune response against influenza virus: a new class of adjuvant?Fish oil metabolites: translating promising findings from bench to bedside to reduce cardiovascular diseasePro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in InflammationResolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formationEndogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury.Specialized pro-resolving lipid mediators in the inflammatory response: An updateNovel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?The influence of Cox-2 and bioactive lipids on hematological cancers.Significance of lipid mediators in corneal injury and repair.Resolution of Cochlear Inflammation: Novel Target for Preventing or Ameliorating Drug-, Noise- and Age-related Hearing Loss.Resolution, the grail for healthy ocular inflammation.Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model.The resolvin D1 analogue controls maturation of dendritic cells and suppresses alloimmunity in corneal transplantationEffect of 15-lipoxygenase metabolites on angiogenesis: 15(S)-HPETE is angiostatic and 15(S)-HETE is angiogenic.Resolvins: natural agonists for resolution of pulmonary inflammation.Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins.Macrophage depletion impairs corneal wound healing after autologous transplantation in miceNovel anti-inflammatory--pro-resolving mediators and their receptorsAspirin-triggered lipoxin A4 (15-epi-LXA4) increases the endothelial viability of human corneas storage in Optisol-GS.Resolvins and protectins in inflammation resolution.Inhibition of Corneal Inflammation by the Resolvin E1.Celastrol nanoparticles inhibit corneal neovascularization induced by suturing in rats.Estrogen negatively regulates epithelial wound healing and protective lipid mediator circuits in the corneaOcular surface immunity: homeostatic mechanisms and their disruption in dry eye diseaseResolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs.Active Pedicle Epithelial Flap Transposition Combined with Amniotic Membrane Transplantation for Treatment of Nonhealing Corneal UlcersConjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammationResolvin D1 mitigates energy metabolism disorder after ischemia-reperfusion of the rat lung.Lipid metabolites in the pathogenesis and treatment of neovascular eye disease.Resolvin D1 and aspirin-triggered resolvin D1 regulate histamine-stimulated conjunctival goblet cell secretion.Anti-inflammatory Agents: Present and FutureResolvin D1 reverts lipopolysaccharide-induced TJ proteins disruption and the increase of cellular permeability by regulating IκBα signaling in human vascular endothelial cells.Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology.Essential fatty acids and their metabolites as modulators of stem cell biology with reference to inflammation, cancer, and metastasis.The role of the tissue omega-6/omega-3 fatty acid ratio in regulating tumor angiogenesis.New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration.
P2860
Q27315037-4FF7D0C2-5081-4A7D-8E1B-D2998A7BEB10Q27691454-251BDBE5-B339-452A-8DDE-E0BAD2E1F2FAQ28244502-8B6912B7-1208-44EB-926C-4D638EF10920Q28251512-7AC1F6C6-434C-4B4E-8F25-F2E5EE4707A9Q28385429-8369E632-39D6-406B-9EFC-1D11F63C15B3Q28716294-12151C69-D065-45AA-B85C-63F53928A628Q30514238-E7EBF4BD-8E34-49FE-AB06-B21029785014Q33556241-76AA2565-5CAF-40CB-B270-5758186C10A7Q33657562-4C1193CF-E65F-4F8C-A804-7D2778FA659FQ33683210-F0A7FC8D-B86E-4CE0-8817-292E0DB925DEQ33688673-BF7EE5A3-AB3B-4C04-BBAD-075E9E8D3CD2Q33784586-E499BDC2-99A1-4A3F-AEA5-8CCBA92E1003Q33882297-80F3CDAA-C276-4C0F-BA21-854CA869E012Q34126362-DF3BF815-9F86-466A-B0C3-F5A29FD6C9C3Q34206822-24248198-0DD7-49E9-8534-6D0D6AAE3143Q34230865-5172E082-035F-455F-9AFB-F8DD730A7B1BQ34263826-6F26F049-4111-40C6-B7A7-3E337C89628BQ34448487-0038ACEF-BE9F-4D70-9C5E-EE3C1C968668Q34522097-4975BC91-F7A0-43C8-B028-B6307AD25B1EQ34685137-C0124748-6079-4123-9E46-C7B2D23DA230Q34982051-8834DDAD-2FD3-4333-8166-DC19B81CC6CBQ35024234-9D1B1CAD-064E-4679-A976-F749986CA93BQ35332873-105D3A3E-8F74-4162-81C1-9A00265F0614Q35560054-ED1E80F4-DB76-458D-94F7-58A09E6C324BQ35817938-038AFCDA-2EC1-4742-B9F8-1B13A65FE7BDQ35863828-7A2D775D-CF6A-4127-A29E-ACBE468D5EBBQ35907009-8492552D-2CFF-4E89-B92C-611DD3EAC3DBQ35951840-4233F2B3-D3B5-42B7-ADEF-6B7FD4D9A155Q36188094-4F66CFE4-D9F4-489B-99EA-383E10B83BCCQ36495510-1D23E85E-EA76-4C45-ADE9-D7AE8CDAE6A8Q36725063-6860E94B-5312-44DB-A955-74F251314323Q37011339-D15B3D73-A3F6-4DCE-8DBE-732A78E47039Q37092941-BEC3797D-0527-45D8-B9C8-C5E4AFACB86DQ37118156-2F570283-05D8-4017-A67C-FB5F50CB477CQ37409822-DF96D507-1A2E-497B-93A3-5F0175C06BF7Q37466085-8965487F-50E7-43E0-806C-AFEDB59C555BQ37603197-765A6AC8-A1DF-4EFC-A42B-8E7612133680Q37946729-6E43B3F9-214C-4300-BDFA-B9AF36E7A10FQ38054491-548C518D-DD2B-474F-9EA7-4EEAB38505BAQ38627502-94CD0D3D-F674-414D-997B-70A6E68026B3
P2860
Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Anti-angiogenesis effect of th ...... pro-resolving lipid mediators.
@ast
Anti-angiogenesis effect of th ...... pro-resolving lipid mediators.
@en
type
label
Anti-angiogenesis effect of th ...... pro-resolving lipid mediators.
@ast
Anti-angiogenesis effect of th ...... pro-resolving lipid mediators.
@en
prefLabel
Anti-angiogenesis effect of th ...... pro-resolving lipid mediators.
@ast
Anti-angiogenesis effect of th ...... pro-resolving lipid mediators.
@en
P2093
P2860
P356
P1476
Anti-angiogenesis effect of th ...... pro-resolving lipid mediators.
@en
P2093
Charles N Serhan
Daniel R Saban
Makoto Arita
Nan Chiang
Qiang Zhang
Sunil K Chauhan
Yiping Jin
P2860
P304
P356
10.1167/IOVS.08-2462
P407
P577
2009-04-30T00:00:00Z